Advanced Search

Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2010 December;52(4) > Panminerva Medica 2010 December;52(4):331-8

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEPANMINERVA MEDICA

A Journal on Internal Medicine

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6

Frequency: Quarterly

ISSN 0031-0808

Online ISSN 1827-1898

 

Panminerva Medica 2010 December;52(4):331-8

IMAGING AND FOCAL THERAPY IN PROSTATE AND KIDNEY CANCER PART II: FOCUS ON KIDNEY 

Laparoscopic and percutaneous cryotherapy for renal neoplasms

Stroup S. P., Kopp R. P., Derweesh I. H.

Division of Urology/Department of Surgery, University of California San Diego, School of Medicine, La Jolla, California, USA

Incidence of renal cell carcinoma is increasing. There has been a shift towards utilization of nephron sparing surgery when feasible. Minimally invasive ablative treatments such as laparoscopic and percutaneous renal cryoablation aim to treat renal tumors with the two goals of cancer eradication and reduced morbidity compared to excisional surgical approaches. In this article, we review the basis of cryobiology and examine the current role of renal cryoablation and analyze the current literature focusing on laparoscopic and percutaneous approaches and discuss future directions and refinements in cryosurgical technology. While renal cryoablation is associated with higher local retreatment rates compared to radical or partial nephrectomy, emerging reports of intermediate-term oncological outcomes suggest disease-specific survival approaching that of extirpative surgery. Further follow up is needed to elucidate the long-term oncologic outcomes of and effects on renal function by renal cryoablation.

language: English


FULL TEXT  REPRINTS

top of page